COMMUNIQUÉS West-GlobeNewswire

Extendicare Announces Agreement to Acquire Closing the Gap Healthcare Group
01/05/2025
MARKHAM, Ontario, May 01, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“ Extendicare ” or the “ Company ”) (TSX: EXE) announced today that its wholly owned home health care subsidiary, ParaMed Inc. (“ ParaMed ” or the “ [...]
Windtree Announces Strategic Transaction to Drive Revenue Generation in Support of Ongoing Therapeutic Pipeline Development
01/05/2025
Initial transaction provides the right to buy the target asset which may provide consistent revenue to Windtree while it continues to develop its biotech pipeline drug candidates WARRINGTON, Pa., May 01, 2025 (GLOBE [...]
Kronos Bio Enters into Agreement to Be Acquired by Concentra Biosciences for $0.57 in Cash per Share Plus a Contingent Value Right
01/05/2025
CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. ("Kronos Bio") (Nasdaq: KRON), a biotechnology company that has been developing small molecule therapeutics to address cancers and other diseases [...]
4DMT Announces RMAT Designation Granted by FDA for 4D-150 for DME
01/05/2025
EMERYVILLE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]
Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors
01/05/2025
SAN CARLOS, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today [...]
Spur Therapeutics to Participate in Citizens JMP 2025 Life Sciences Conference
01/05/2025
LONDON, May 01, 2025 (GLOBE NEWSWIRE) -- Spur Therapeutics today announced that Chief Executive Officer Michael Parini will present a corporate overview at the Citizens JMP 2025 Life Sciences Conference being held May 7 [...]
UNITY Biotechnology to Present at the ARVO 2025 Annual Meeting
01/05/2025
SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today [...]
Apogee Therapeutics to Participate at the Bank of America 2025 Health Care Conference
01/05/2025
SAN FRANCISCO and BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), today announced that members of management will present at the Bank of America Health Care Conference on Tuesday, May [...]
Rezolute to Participate in Upcoming Investor Conferences
01/05/2025
REDWOOD CITY, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on significantly improving outcomes for individuals with [...]
Elutia to Report First Quarter 2025 Financial Results on Thursday, May 8, 2025
01/05/2025
SILVER SPRING, Md., May 01, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its first quarter 2025 [...]
Cidara Therapeutics Announces Promotion of Nicole Davarpanah to Chief Medical Officer and Corrina Pavetto to SVP, Clinical Development
01/05/2025
SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced [...]
Akebia Therapeutics to Report First Quarter 2025 Financial Results and Discuss Recent Business Highlights
01/05/2025
Akebia to Host Conference Call on May 8, 2025, at 8:00 a.m. EDT CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the [...]
electroCore’s Truvaga™ Now Works with the Apple Health app
01/05/2025
ROCKAWAY, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that its flagship wellness product, Truvaga Plus, now [...]
Neurogen Announces Partnership with NeuroX, a subsidiary of American TelePhysicians
01/05/2025
Neurogen’s Brain Health Care Ecosystem Accelerates Access to Early Detection Technology for Alzheimer’s dementia and Mild Cognitive Impairment CHICAGO, May 01, 2025 (GLOBE NEWSWIRE) -- Neurogen Biomarking announced it [...]
Foghorn Therapeutics Appoints Neil Gallagher and Stuart Duty to its Board of Directors
01/05/2025
CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Foghorn ® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting [...]
Ligand to Participate in May Investor Conferences
01/05/2025
JUPITER, Fla., May 01, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its senior management team will participate in the following upcoming investor conferences: H.C. [...]
BioStem to Showcase its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Spring Meeting
01/05/2025
Company to co-exhibit with strategic partner Venture Medical, LLC, highlighting collaborative innovation in chronic wound care management Three accepted scientific posters will feature BioStem’s advanced allograft [...]
Microbix Presenting at the 2025 Bloom Burton Conference
01/05/2025
MISSISSAUGA, Ontario, May 01, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces it will be attending and [...]
Bio-Path Holdings Achieves Third Pre-Clinical Milestone Confirming Potential of BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
01/05/2025
Data suggest BP1001-A prevents fatty acid-induced insulin resistance in cells HOUSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (OTCQB:BPTH), a biotechnology company leveraging its proprietary DNAbilize [...]

Pages